In conclusion, this study demonstrated that RAB27B had the ability to promote cell proliferation by regulating the PI3K/AKT/P21 pathway and provided an augmented ease of diagnosis and the identification of new candidate targets for HCC therapy. Here, RAB27B is linked to hepatocellular carcinoma.